Form 4: Humana Director Gordon Smith Acquires Additional Restricted Stock Units

Humana Inc. Director Gordon Smith has increased his beneficial ownership by acquiring 136 restricted stock units through a conversion of cash fees, aligning his interests with shareholders.

Summary

• Gordon Smith, a Director of Humana Inc. (HUM), acquired 136 Restricted Stock Units (RSUs) on June 30, 2025.
• The acquisition was a result of the Director's election to convert a cash fee into stock units, which are deferred.
• Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock on a 1-for-1 basis.
• The transaction was exempt under Rule 16(b)-3(d)(1) of the Securities Exchange Act of 1934.
• The price per unit for the acquired RSUs was $242.815.
• Following this transaction, Gordon Smith beneficially owns 254 derivative restricted stock units of this specific type.
• Additionally, Gordon Smith beneficially owns 765 non-derivative Humana Common shares and 783 other derivative restricted stock units from an annual director's fee, deferred until his resignation.

Sentiment

Score: 7

Explanation: The acquisition of additional equity by a director, even if from deferred compensation, indicates a positive alignment of interests and confidence in the company's future, contributing to a moderately positive sentiment.

Positives

• A Director's election to convert cash fees into stock units demonstrates a commitment to the company and aligns their financial interests with those of shareholders.
• The acquisition of additional equity by an insider can be viewed as a positive signal regarding the company's future prospects.

Future Outlook

The document does not contain explicit forward-looking statements or guidance beyond the nature of the restricted stock units being payable upon resignation or at a future date.

Industry Context

This Form 4 filing reflects an individual insider transaction within Humana Inc., a major player in the U.S. healthcare insurance industry. Such transactions are routine disclosures and do not inherently reflect broader industry trends, though insider confidence can be a general indicator.

Comparison to Industry Standards

• The practice of compensating directors with equity, including restricted stock units, is a common corporate governance standard across publicly traded companies, including those in the healthcare sector like UnitedHealth Group (UNH), Elevance Health (ELV), and Cigna Group (CI).
• Deferring stock unit payouts until resignation is also a standard practice for aligning long-term director interests with company performance and retention.
• The conversion of cash fees into equity is a voluntary election often offered to directors, consistent with best practices for promoting insider ownership.

Related Party Transactions

• The acquisition of restricted stock units by Director Gordon Smith from Humana Inc. constitutes a related party transaction, specifically an insider transaction related to compensation.

Stakeholder Impact

• Shareholders: The transaction indicates a director's increased equity stake, potentially signaling confidence and aligning management interests with shareholder value.
• Management: The deferral of stock units until resignation incentivizes long-term commitment and performance.

Next Steps

• The acquired restricted stock units will be payable in Humana Inc. common stock on a 1-for-1 basis upon the Reporting Person's resignation of services as a director.

Key Dates

Recommendation

Keywords

Humana, HUM, SEC Form 4, Insider Trading, Restricted Stock Units, Director Compensation, Equity Acquisition, Corporate Governance, Healthcare, Insurance